BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21863490)

  • 1. Use of proteome arrays to globally identify substrates for E3 ubiquitin ligases.
    Persaud A; Rotin D
    Methods Mol Biol; 2011; 759():215-24. PubMed ID: 21863490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitination screen using protein microarrays for comprehensive identification of Rsp5 substrates in yeast.
    Gupta R; Kus B; Fladd C; Wasmuth J; Tonikian R; Sidhu S; Krogan NJ; Parkinson J; Rotin D
    Mol Syst Biol; 2007; 3():116. PubMed ID: 17551511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-substrate relationships in the ubiquitin system: approaches for identifying substrates of ubiquitin ligases.
    O'Connor HF; Huibregtse JM
    Cell Mol Life Sci; 2017 Sep; 74(18):3363-3375. PubMed ID: 28455558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays.
    Persaud A; Alberts P; Amsen EM; Xiong X; Wasmuth J; Saadon Z; Fladd C; Parkinson J; Rotin D
    Mol Syst Biol; 2009; 5():333. PubMed ID: 19953087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase.
    Guo Z; Song E; Ma S; Wang X; Gao S; Shao C; Hu S; Jia L; Tian R; Xu T; Gao Y
    J Proteome Res; 2012 Oct; 11(10):4847-62. PubMed ID: 22889411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays.
    Andrews PS; Schneider S; Yang E; Michaels M; Chen H; Tang J; Emkey R
    Assay Drug Dev Technol; 2010 Aug; 8(4):471-87. PubMed ID: 20804422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological functions of the HECT family of ubiquitin ligases.
    Rotin D; Kumar S
    Nat Rev Mol Cell Biol; 2009 Jun; 10(6):398-409. PubMed ID: 19436320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SUMO E3 ligase-specific substrates using the HuProt human proteome microarray.
    Cox E; Uzoma I; Guzzo C; Jeong JS; Matunis M; Blackshaw S; Zhu H
    Methods Mol Biol; 2015; 1295():455-63. PubMed ID: 25820740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.
    Wang Y; Argiles-Castillo D; Kane EI; Zhou A; Spratt DE
    J Cell Sci; 2020 Apr; 133(7):. PubMed ID: 32265230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive database of human E3 ubiquitin ligases: application to aquaporin-2 regulation.
    Medvar B; Raghuram V; Pisitkun T; Sarkar A; Knepper MA
    Physiol Genomics; 2016 Jul; 48(7):502-12. PubMed ID: 27199454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BioE3 identifies specific substrates of ubiquitin E3 ligases.
    Barroso-Gomila O; Merino-Cacho L; Muratore V; Perez C; Taibi V; Maspero E; Azkargorta M; Iloro I; Trulsson F; Vertegaal ACO; Mayor U; Elortza F; Polo S; Barrio R; Sutherland JD
    Nat Commun; 2023 Nov; 14(1):7656. PubMed ID: 37996419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics.
    Jordan VN; Ordureau A; An H
    Chembiochem; 2023 Aug; 24(16):e202300108. PubMed ID: 37166757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme reversal to explore the function of yeast E3 ubiquitin-ligases.
    MacDonald C; Winistorfer S; Pope RM; Wright ME; Piper RC
    Traffic; 2017 Jul; 18(7):465-484. PubMed ID: 28382714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein microarrays for the identification of praja1 e3 ubiquitin ligase substrates.
    Loch CM; Eddins MJ; Strickler JE
    Cell Biochem Biophys; 2011 Jun; 60(1-2):127-35. PubMed ID: 21461837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nedd4-like family of E3 ubiquitin ligases and cancer.
    Chen C; Matesic LE
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):587-604. PubMed ID: 17726579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
    Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
    Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HECT-Type E3 Ubiquitin Ligases in Cancer.
    Bernassola F; Chillemi G; Melino G
    Trends Biochem Sci; 2019 Dec; 44(12):1057-1075. PubMed ID: 31610939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics.
    Lill JR; Wertz IE
    Trends Pharmacol Sci; 2014 Apr; 35(4):187-207. PubMed ID: 24717260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases.
    Vittal V; Stewart MD; Brzovic PS; Klevit RE
    J Biol Chem; 2015 Aug; 290(35):21244-51. PubMed ID: 26187467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of Nedd4 ubiquitin ligases and their adaptor protein Ndfip1 in a rat model of ischemic stroke.
    Lackovic J; Howitt J; Callaway JK; Silke J; Bartlett P; Tan SS
    Exp Neurol; 2012 May; 235(1):326-35. PubMed ID: 22417925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.